Amicus Therapeutics, Inc. (FRA:AM6)

Amicus Therapeutics Statistics

Total Valuation

FRA:AM6 has a market cap or net worth of EUR 2.60 billion. The enterprise value is 2.75 billion.

Market Cap	2.60B
Enterprise Value	2.75B

Important Dates

The next estimated earnings date is Wednesday, February 18, 2026.

Earnings Date	Feb 18, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	308.53M
Shares Outstanding	n/a
Shares Change (YoY)	+1.52%
Shares Change (QoQ)	+0.71%
Owned by Insiders (%)	0.87%
Owned by Institutions (%)	103.83%
Float	305.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	15.04
PS Ratio	5.10
PB Ratio	13.24
P/TBV Ratio	170.64
P/FCF Ratio	314.90
P/OCF Ratio	235.18
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 65.37, with an EV/FCF ratio of 333.54.

EV / Earnings	-229.88
EV / Sales	5.35
EV / EBITDA	65.37
EV / EBIT	92.79
EV / FCF	333.54

Financial Position

The company has a current ratio of 2.99, with a Debt / Equity ratio of 1.92.

Current Ratio	2.99
Quick Ratio	1.90
Debt / Equity	1.92
Debt / EBITDA	9.04
Debt / FCF	45.69
Interest Coverage	0.74

Financial Efficiency

Return on equity (ROE) is -6.87% and return on invested capital (ROIC) is 3.33%.

Return on Equity (ROE)	-6.87%
Return on Assets (ROA)	2.61%
Return on Invested Capital (ROIC)	3.33%
Return on Capital Employed (ROCE)	5.15%
Revenue Per Employee	1.02M
Profits Per Employee	-24,016
Employee Count	499
Asset Turnover	0.72
Inventory Turnover	0.42

Taxes

In the past 12 months, FRA:AM6 has paid 16.23 million in taxes.

Income Tax	16.23M
Effective Tax Rate	382.24%

Stock Price Statistics

The stock price has decreased by -8.06% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-8.06%
50-Day Moving Average	7.48
200-Day Moving Average	6.57
Relative Strength Index (RSI)	68.45
Average Volume (20 Days)	49

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.48

Income Statement

In the last 12 months, FRA:AM6 had revenue of EUR 510.28 million and -11.98 million in losses. Loss per share was -0.04.

Revenue	510.28M
Gross Profit	458.10M
Operating Income	29.42M
Pretax Income	4.25M
Net Income	-11.98M
EBITDA	35.90M
EBIT	29.42M
Loss Per Share	-0.04

Balance Sheet

The company has 224.87 million in cash and 377.42 million in debt, giving a net cash position of -152.54 million.

Cash & Cash Equivalents	224.87M
Total Debt	377.42M
Net Cash	-152.54M
Net Cash Per Share	n/a
Equity (Book Value)	196.39M
Book Value Per Share	0.64
Working Capital	336.77M

Cash Flow

In the last 12 months, operating cash flow was 11.06 million and capital expenditures -2.80 million, giving a free cash flow of 8.26 million.

Operating Cash Flow	11.06M
Capital Expenditures	-2.80M
Free Cash Flow	8.26M
FCF Per Share	n/a

Margins

Gross margin is 89.77%, with operating and profit margins of 5.77% and -2.35%.

Gross Margin	89.77%
Operating Margin	5.77%
Pretax Margin	0.83%
Profit Margin	-2.35%
EBITDA Margin	7.04%
EBIT Margin	5.77%
FCF Margin	1.62%

Dividends & Yields

FRA:AM6 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.52%
Shareholder Yield	-1.52%
Earnings Yield	-0.46%
FCF Yield	0.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:AM6 has an Altman Z-Score of -0.73 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.73
Piotroski F-Score	4